Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its Ligands*
暂无分享,去创建一个
P. Loetscher | J. Gong | Pius Loetscher | Ian Clark-Lewis | Ivan Mattioli | Jiang-Hong Gong | I. Clark‐Lewis | Ivan Mattioli
[1] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[2] B. Sykes,et al. Structure‐activity relationships of chemokines , 1995, Journal of leukocyte biology.
[3] D. Jarrossay,et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.
[4] A. Gottlieb,et al. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques , 1988, The Journal of experimental medicine.
[5] M. Baggiolini,et al. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. , 1991, The Journal of biological chemistry.
[6] M. Baggiolini,et al. The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.
[7] P. Murphy. International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature , 2002, Pharmacological Reviews.
[8] E Lazzeri,et al. Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in hum , 2001, Blood.
[9] L. Trentin,et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. , 1999, The Journal of clinical investigation.
[10] Bernhard Moser,et al. Lymphocyte traffic control by chemokines , 2001, Nature Immunology.
[11] R. Doms,et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .
[12] B. Dewald,et al. RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.
[13] B. Lindner,et al. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I‐TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine , 2002, Journal of leukocyte biology.
[14] H. Weiner,et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Patel,et al. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. , 2001, Clinical immunology.
[16] M. Baggiolini,et al. HIV blocked by chemokine antagonist , 1996, Nature.
[17] Simon A. Jones,et al. Chemokine Antagonists That Discriminate between Interleukin-8 Receptors , 1997, The Journal of Biological Chemistry.
[18] B. Sykes,et al. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. , 2002, Biochemistry.
[19] D. Dorfman,et al. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. , 2000, Blood.
[20] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[21] P. Loetscher,et al. Agonistic and antagonistic activities of chemokines , 2001, Journal of leukocyte biology.
[22] Brian A. Hemmings,et al. G-Protein-coupled Receptors and Fcγ-receptors Mediate Activation of Akt/Protein Kinase B in Human Phagocytes* , 1997, The Journal of Biological Chemistry.
[23] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[24] M. Chilosi,et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.
[25] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Peck,et al. A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.
[27] M. Baggiolini,et al. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.
[28] Elias Lolis,et al. Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.
[29] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[30] B. Dewald,et al. N-terminal Peptides of Stromal Cell-derived Factor-1 with CXC Chemokine Receptor 4 Agonist and Antagonist Activities* , 1998, The Journal of Biological Chemistry.
[31] Juan Pablo Albar,et al. CXCR3 Chemokine Receptor Distribution in Normal and Inflamed Tissues: Expression on Activated Lymphocytes, Endothelial Cells, and Dendritic Cells , 2001, Laboratory Investigation.
[32] E. Hudson,et al. Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] M. Baggiolini,et al. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration , 1986, Nature.
[34] M. Baggiolini,et al. Blocking Chemokine Receptors , 1997, The Journal of experimental medicine.
[35] P. Loetscher,et al. Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.
[36] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[37] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[38] R. Rabin,et al. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.
[39] M. Serio,et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.
[40] J. Anderson,et al. Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. , 1997, Methods in enzymology.
[41] J. Ravetch,et al. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.
[42] Jakob S. Jensen,et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.
[43] P. Libby,et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.
[44] J. Michel,et al. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study , 2001, The Journal of pathology.
[45] S. Narula,et al. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. , 2001, Molecular pharmacology.
[46] G. Werner-Felmayer,et al. Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity. , 2001, European journal of biochemistry.
[47] M. Baggiolini,et al. CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.
[48] E. De Clercq,et al. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. , 1999, Journal of immunology.
[49] W. Hancock,et al. Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.
[50] James G. Boyd,et al. Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.
[51] M. Parmentier,et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. , 2001, Blood.
[52] C. Mackay,et al. T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.
[53] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[54] M. Baggiolini,et al. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. , 2001, Blood.
[55] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[56] J. Farber. HuMig: a new human member of the chemokine family of cytokines. , 1993, Biochemical and biophysical research communications.
[57] J. Edwardson,et al. Endocytosis and recycling of G protein-coupled receptors. , 1997, Trends in pharmacological sciences.
[58] F. Spertini,et al. CXCR3 Internalization Following T Cell-Endothelial Cell Contact: Preferential Role of IFN-Inducible T Cell α Chemoattractant (CXCL11)1 , 2001, The Journal of Immunology.
[59] ANTAGONISTS OF MONOCYTE CHEMOATTRACTANT PROTEIN 1 IDENTIFIED BY MODIFICATION OF FUNCTIONALLY CRITICAL NH2-TERMINAL RESIDUES , 1995 .
[60] A. Luster,et al. Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection , 2001, The Journal of experimental medicine.
[61] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[62] B. Dewald,et al. Interleukin-8 antagonists generated by N-terminal modification. , 1993, The Journal of biological chemistry.
[63] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[64] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[65] C. Mackay,et al. The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.